CONMED Corporation Announces Second Quarter Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/30/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- BioNTech ends colorectal cancer mRNA therapy trial early
- Needham sees mature node semiconductor strength in latest tracker
Conmed (CNMD) Tops Q2 EPS by 9c, Offers Guidance
July 28, 2021 4:13 PM EDTConmed (NASDAQ: CNMD) reported Q2 EPS of $0.71, $0.09 better than the analyst estimate of $0.62. Revenue for the quarter came in at $255.2 million versus the consensus estimate of $248.31 million.
GUIDANCE:
Conmed sees FY2021 EPS of $3.15-$3.25, versus the consensus of $3.15. Conmed sees... More
